Start-Up Previews (2/03)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Neuropsychiatric Drug Discovery, features profiles of Afecta Pharmaceuticals Inc., DarPharma Inc., Intra-Cellular Therapies Inc. and Neuro3d SA. Plus these Start-Ups across Health Care: Chimerix Inc., IDgene Pharmaceuticals Ltd. and Impres Medical Inc.
You may also be interested in...
The US agency plans to hold a virtual workshop that will use breakout sessions to get stakeholder feedback on specific hurdles preventing more pediatric devices coming to market.
France plans to begin issuing manufacturing quality certificates so firms can import ordinary cosmetics into China without animal testing under a 2020 draft regulation. The Personal Care Products Council is working to find a comparable solution for US manufacturers.
The calcineurin inhibitor, only the second drug to be approved by the US FDA for lupus nephritis, will be competing against GlaxoSmithKline’s Benlysta.